41.6 F
Muscatine
Tuesday, November 24, 2020
More

    Governor Reynolds announces $2 million in CARES Act funding for COVID-19 nanovaccine development in Iowa

    Kim Reynolds
    Kim Reynoldshttps://governor.iowa.gov/about-the-governor
    As Iowa’s 43rd Governor, Kim Reynolds is determined to make sure that Iowa’s success is every Iowan’s success. Whether it’s preparing Iowans for cutting-edge careers, fighting for education, improving healthcare and mental health access, or empowering our rural communities, Kim’s priorities are making a difference in all four corners of the state. Her vision keeps Iowans at the center of all decisions, especially in the area of fiscal responsibility. Kim knows that when Iowa taxpayers are able to keep more of their money, great things happen. She also believes in redemption. Kim’s justice reform initiatives carefully balance second chances with victim rights. As Governor, Kim’s strong voice for international trade, agriculture, and advanced manufacturing is opening new markets and maintaining relationships with leaders in China, Mexico, Canada, Israel, Thailand, Vietnam, the Philippines, Germany, Brazil and Argentina, to name just a few. Although she’s traveled the world telling Iowa’s story, Kim is still a small-town girl at heart with common-sense values. These principles are reflected in the Governor’s Empower Rural Iowa initiative and Future Ready Iowa. At age 57, Kim earned a bachelor’s degree from Iowa State University. Then, nearly two years later, on Nov. 4, 2018, she was elected by Iowans to become their first woman Governor. Family means everything to Kim and her husband, Kevin. They have three daughters (Jennifer, Nicole and Jessica) who are happily married, and Kim and Kevin love spending time with their 10 very active grandchildren.

    Muscatine Living

    Mission Pawsible Nov. 25

    Adopt Jersey! Breed: female, calico domestic short hair Age: Five-months-old Jersey gets along with everyone! She has lived with other cats and...

    Five Investment Tasks to Tackle by Year-End

    1. Evaluate Your Investment Portfolio To identify potential changes to your investment strategy, consider the following questions when reviewing your...

    Preparing fruits for winter

    By Gail Nonnecke--Iowa State University Extension and Outreach AMES, Iowa--There is still plenty to do during the fall in preparation...

    This content provided by the Office of the Governor of Iowa, Kim Reynolds as a press release.

    Governor Reynolds announces $2 million in CARES Act funding for COVID-19 nanovaccine development in Iowa

    [email protected]
    Fri, 10/30/2020 – 12:15

    Iowa State University and the University of Iowa will partner to develop and test a nanovaccine

    DES MOINES – Governor Kim Reynolds today announced she has set aside $2 million in CARES Act funding to support the development of a next-generation COVID-19 vaccine through a partnership between Iowa State University and the University of Iowa. 

    The funding and collaboration with Iowa industry partners, including startups, will help ISU and the U of I leverage their patented technology to advance a COVID-19 nanovaccine candidate that will address the limitations of vaccines already under development.   

    “Through this important partnership, Iowa is supporting those on the frontlines of nanovaccine development,” Gov. Kim Reynolds said. “Iowa’s COVID19 nanovaccine candidate will not require needles or refrigeration, and could provide long-term immunity from just a single dose. I am proud of the role Iowa State University and the University of Iowa are playing in this cutting-edge development.”  

    This approach draws on ISU’s strengths in nanovaccine research and development, nanovaccine platform technology and animal health, as well as the U of I’s expertise in SARS virology, immunity, and unique animal models.  

    “The Nanovaccine Institute based at Iowa State was established in 2013 with this kind of global health challenge in mind,” said Iowa State’s Balaji Narasimhan, the project leader, director of the Nanovaccine Institute and an Anson Marston Distinguished Professor in Engineering. “We’ve created a team that can innovate and move our ideas beyond the lab. We’re ready to meet the urgent need for a COVID-19 vaccine.”  

    Michael Wannemuehler, associate director of the Nanovaccine Institute and a professor of veterinary microbiology and preventive medicine, is also leading the project at Iowa State.   

    The UI effort is being led by Kevin L. Legge, Ph.D., professor of pathology and director of the Pathology Research Flow Cytometry Core in the UI Carver College of Medicine, along with co-investigators Stanley Perlman, Ph.D., MD, professor of microbiology and immunology,  and of pediatrics, in the UI Carver College of Medicine, and Thomas Waldschmidt, Ph.D., Clement T. and Sylvia H. Hanson Chair in Immunology in the Department of Pathology.  

    “This important funding will build on our existing successful partnership between the University of Iowa and Iowa State University and greatly aid in our efforts to bring safe, effective, mucosal-based nanoparticle vaccines against respiratory virus infections to the community,” Legge said.  “Our prior work using these nanovaccines against influenza virus has shown that we are able to induce a broader and more sustained protective response which positions one’s immunity at the sites of viral entry, therein speeding up the response time versus what occurs with current influenza vaccines. These funds will allow us to transfer the lessons learned on influenza vaccines toward the creation of a safe, effective and long-lasting mucosal vaccine against SARS-CoV2/COVID-19.”  

    The collaboration between the two universities and industry partners also will further cement the state’s reputation as a biosciences epicenter. A 2017 report identified Iowa’s competitive advantages in the biosciences, including vaccines and immunotherapeutics.   

    “Today’s announcement puts to use Iowa’s unique assets and attributes in the fight against COVID-19 and fuels economic development by establishing the state as a hub for vaccine development and attracting new investments and companies,” said Debi Durham, director of the Iowa Economic Development Authority and Iowa Finance Authority.  

    This content provided by the Office of the Governor of Iowa, Kim Reynolds as a press release.

    Latest News

    City’s leaf collection effort passes halfway mark

    MUSCATINE, Iowa - The City of Muscatine is halfway through the second round of fall leaf collection and, despite the...

    Board of Canvass Meeting – November 30, 2020 – Teleconference Only

    This content provided by the Office of the Governor of Iowa, Kim Reynolds as a press release. Board of Canvass Meeting - November 30, 2020...

    EXECUTIVE COUNCIL – November 30, 2020 – Cancelled

    This content provided by the Office of the Governor of Iowa, Kim Reynolds as a press release. EXECUTIVE COUNCIL - November 30, 2020 - Cancelled Meeting...

    Gov. Reynolds completes 99 County Tour

    This content provided by the Office of the Governor of Iowa, Kim Reynolds as a press release. Gov. Reynolds completes 99 County Tour Mon, 11/23/2020...

    20 years of love: Two Weeks of Love marks 20 years in 2020

    MUSCATINE, Iowa--Since 2000, Two Weeks of Love's twin events, Toy Time and Freezin' for Food, have helped the Salvation Army ensure families throughout the...

    More Articles Like This